| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2505918 | International Journal of Pharmaceutics | 2008 | 7 Pages |
Abstract
Compared to the results obtained previously with PC-based arsonoliposomes, both the DSPC-based and Pegylated-arsonoliposomes have better bioavailability. This proves that arsonoliposome lipid composition (and consequently their integrity) influences their pharmacokinetic profile. Thus, the proper arsonoliposome composition should be used according to the intended application.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
Paraskevi Zagana, Maria Haikou, Pavlos Klepetsanis, Eleftheria Giannopoulou, Panayiotis V. Ioannou, Sophia G. Antimisiaris,